Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
One of the most difficult balancing actsin clinical psychopharmacology practice isminimizing the risks of untreated depressionin pregnant women while also minimizingthe risks of antidepressant treatment.Major depression is estimated tooccur in 9.4% to 12.7% of pregnantwomen1 and to recur in over two thirds ofwomen who discontinue antidepressantmedication while pregnant.2 Antenatal depressivesymptoms can compromise outcomesfor women and their offspring.3
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
Please sign in or purchase this PDF for $40.00.
Save
Share
Cite
